10.3978/j.issn.2304-3881.2013.03.01
Comparison of high-intensity focused ultrasound therapy and radiofrequency ablation for recurrent hepatocellular carcinoma
Hepatocellular carcinoma (HCC), which accounts for more than 90% of primary liver cancer, is a major health problem worldwide, and is the third most common cause of cancer-related death. It is the fifth most prevalent cancer in men and the seventh in women (1-3). The prognosis for untreated HCC is generally poor, and curative treatments consist of surgical resection, radiofrequency ablation (RFA), and liver transplantation (1-3).
2
2019-07-18(万方平台首次上网日期,不代表论文的发表时间)
共3页
168-170